🇺🇸 FDA
Patent

US 8216565

GP100-specific T cell receptors and related materials and methods of use

granted A61KA61K38/00A61P

Quick answer

US patent 8216565 (GP100-specific T cell receptors and related materials and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61P, A61P35/04